Lord Kamall Portrait

Lord Kamall

Conservative - Life peer

Joined House of Lords: 28th January 2021

Shadow Minister (Health and Social Care)

(since September 2024)

Communications and Digital Committee
31st Jan 2023 - 30th Jan 2025
Parliamentary Under-Secretary (Department for Digital, Culture, Media and Sport)
20th Sep 2022 - 29th Oct 2022
Parliamentary Under-Secretary (Department of Health and Social Care)
17th Sep 2021 - 20th Sep 2022
COVID-19 Committee
10th Jun 2021 - 17th Sep 2021


Division Voting information

During the current Parliament, Lord Kamall has voted in 184 divisions, and 1 time against the majority of their Party.

2 Jul 2025 - House of Lords (Hereditary Peers) Bill - View Vote Context
Lord Kamall voted Aye - against a party majority and against the House
One of 23 Conservative Aye votes vs 82 Conservative No votes
Tally: Ayes - 84 Noes - 263
View All Lord Kamall Division Votes

Debates during the 2024 Parliament

Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.

Sparring Partners
Baroness Merron (Labour)
Parliamentary Under-Secretary (Department of Health and Social Care)
(186 debate interactions)
Baroness Blake of Leeds (Labour)
Baroness in Waiting (HM Household) (Whip)
(28 debate interactions)
Lord Scriven (Liberal Democrat)
Liberal Democrat Lords Spokesperson (Health)
(15 debate interactions)
View All Sparring Partners
Legislation Debates
Mental Health Act 2025
(21,734 words contributed)
Tobacco and Vapes Bill 2024-26
(10,950 words contributed)
View All Legislation Debates
View all Lord Kamall's debates

Lords initiatives

These initiatives were driven by Lord Kamall, and are more likely to reflect personal policy preferences.


Lord Kamall has not introduced any legislation before Parliament

Lord Kamall has not co-sponsored any Bills in the current parliamentary sitting


Latest 50 Written Questions

(View all written questions)
Written Questions can be tabled by MPs and Lords to request specific information information on the work, policy and activities of a Government Department
3rd Dec 2025
To ask His Majesty's Government what advice the Attorney General provided about the legality and applicability to Northern Ireland of the generational smoking ban in the Tobacco and Vapes Bill, and the compatibility of that ban with the Windsor Framework.

The Law Officers sit on the Parliamentary Business and Legislation Committee. As part of the process of approving a government Bill for introduction, as set out in the published Guide to Making Legislation, a legal issues memorandum is prepared for this Committee. This will set out all relevant legal issues.

Whether the Law Officers have been asked to provide advice outside of the PBL process is covered by the Law Officers’ Convention. This Convention provides that whether or not the Law Officers have been asked to provide advice, and the contents of any such advice, is not disclosed outside Government.

Lord Hermer
Attorney General
3rd Dec 2025
To ask His Majesty's Government what advice the Attorney General provided about the proportionality and applicability to Northern Ireland under World Trade Organization rules of the generational smoking ban in the Tobacco and Vapes Bill, and the likelihood of a legal challenge at the World Trade Organization.

The Law Officers sit on the Parliamentary Business and Legislation Committee. As part of the process of approving a government Bill for introduction, as set out in the published Guide to Making Legislation, a legal issues memorandum is prepared for this Committee. This will set out all relevant legal issues.

Whether the Law Officers have been asked to provide advice outside of the PBL process is covered by the Law Officers’ Convention. This Convention provides that whether or not the Law Officers have been asked to provide advice, and the contents of any such advice, is not disclosed outside Government.

Lord Hermer
Attorney General
17th Sep 2025
To ask His Majesty's Government what steps they are taking to improve the collection and publication of national data on drowning incidents, including demographic information, to inform targeted prevention policies.

The information requested falls under the remit of the UK Statistics Authority.

Please see the letter attached from the National Statistician and Chief Executive of the UK Statistics Authority.

The Lord Kamall

House of Lords

London

SW1A 0PW

22 September 2025

Dear Lord Kamall,

As Acting National Statistician, I am responding to your Parliamentary Question asking what steps are being taken to improve the collection and publication of national data on drowning incidents, including demographic information, to inform targeted prevention policies (HL10639).

The Office for National Statistics (ONS) produces mortality statistics using information provided on death certificates. The ONS codes cause of death using the International Cause of Death (ICD-10). The ICD-10 codes for accidental drowning and submersion are W65 to W74.

The ONS publishes statistics on mortality by specific cause each year, in our Deaths

registered summary statistics [1]. Numbers of deaths for 2024 were published on 20 May 2025, and age-standardised mortality rates will be published on 9 October 2025. Table 3 in that publication presents deaths by specific causes, including accidental drowning and submersion, by sex and five-year age bands. Those published 2024 figures by age and sex are summarised with wider age bands in the table below.

The ONS is currently exploring methods to improve the timeliness of our mortality statistics. We launched a consultation earlier this year asking users about the value of reporting death occurrences rather than registrations for suicide statistics [2], and the same questions are being considered for wider mortality outputs too. This includes assessing the accuracy of “nowcasting”: estimating the number of recent death occurrences, by cause, using factors such as the number registered in the past week and trends in registration delays for that cause.

Death certification reform was also implemented in September 2024 [3], which included adding an ethnicity field to the death certificate for the first time in England and Wales. This aims to improve future reporting of deaths by ethnicity and will enable us to produce further demographic breakdowns in future.

Yours sincerely,

Emma Rourke

Table 1: Number of deaths registered by sex, age group and ONS short list of cause of death code, 2024, England and Wales

ICD-10 code

Underlying cause

Sex

All ages

Aged under 1 year

Aged 01 to 19 years

Aged 20 to 64 years

Aged 65 years and above

W65 to W74

Accidental drowning and submersion

Males

213

1

23

129

60

W65 to W74

Accidental drowning and submersion

Females

83

1

12

38

32

Notes:

1. Figures are for deaths registered rather than deaths occurred. For more information see our Impact of registration delays publication [4].

2. Figures include non-residents.

3. Based on underlying cause of death.

4. The Office for National Statistics (ONS) short list for cause of death is based on a standard tabulation list developed by the ONS, in consultation with the Department of Health (now the Department of Health and Social Care, DHSC). For more information about the codes included, see our User guide to mortality statistics [5].

5. Figures for deaths aged under 1 year exclude deaths under 28 days, which are registered with separate neonatal death certificate from which it is not possible to assign an underlying cause of death. For more information see the childhood mortality section of our User guide to mortality statistics.

[1]https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/d eathsregisteredsummarystatisticsenglandandwales

[2]https://consultations.ons.gov.uk/external-affairs/user-requirements-for-official-suicide-statistics/

[3]https://www.gov.uk/government/collections/death-certification-reform-and-the-introduction-ofmedical-examiners

[4]https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/im pactofregistrationdelaysonmortalitystatisticsinenglandandwales/latest

[5]https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/methodolo gies/userguidetomortalitystatisticsjuly2017#ons-short-list-of-cause-of-death

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
19th Mar 2025
To ask His Majesty's Government what is their estimate of the number of days of work that were lost due to asthma in the UK in each year since 2010 for which there are data available.

The information requested falls under the remit of the UK Statistics Authority.

Please see the letter attached from the National Statistician and Chief Executive of the UK Statistics Authority.

The Lord Kamall

House of Lords

London

SW1A 0PW

21 March 2025

Dear Lord Kamall,

As National Statistician and Chief Executive of the UK Statistics Authority, I am responding to your Parliamentary Question asking for an estimate of the number of days of work that were lost due to asthma in the UK in each year since 2010 for which there are data available (HL5962).

The Office for National Statistics (ONS) collects information on the labour market status of individuals through the Labour Force Survey (LFS), which is a survey of people resident in households in the UK. The LFS also collects information on whether respondents have missed days off work due to illness and/or injury.

Unfortunately, we do not collect information regarding the type of sickness at a level of detail to identify those suffering from asthma specifically, but we can provide the number of working days lost due to respiratory conditions.

We publish estimates of the number of working days lost through sickness absence, including the number of working days lost due to respiratory conditions, in our Sickness absence in the UK labour market: 2022 article1. This article is due to be updated to include 2023 and 2024 estimates on 1 May 2025. This update will also include revisions to estimates from 2019 to 2022. We will send the updated data to you once it has been published.

Yours sincerely,

Professor Sir Ian Diamond

Table 1 contains LFS estimates of the number, and percentage, of working days lost due to respiratory conditions from 2012 to 2022, the latest data currently available.

Table 1: Number and percentage of working days lost due to respiratory conditions, between 2012 and 2022.

Number of working days lost due to respiratory conditions (millions)

Percentage of working days lost due to respiratory conditions (% of all working days lost)

2022

16.2

8.7

2021

10.0

6.7

2020

6.4

5.5

2019

5.6

4.0

2018

3.9

2.8

2017

3.7

2.8

2016

5.4

3.9

2015

5.4

3.9

2014

6.8

5.0

2013

5.8

4.4

2012

4.4

3.3

Baroness Anderson of Stoke-on-Trent
Baroness in Waiting (HM Household) (Whip)
10th Feb 2026
To ask His Majesty's Government what plans they have to review policy and legislation to ensure that healthcare mutuals have access to the same opportunities for growth, investment and regulatory support as mutuals in the financial sector.

DBT, as part of the 2025 Autumn Budget announcements, launched a Call for Evidence on Business Support for Co-operatives and Mutuals. This was open across Great Britain for 12 weeks and closed on 18th February. DBT is now analysing responses and these responses will inform any potential business support policy for the co-operative and mutual businesses.

DBT ensured that for Financial Year 25/26 Growth Hubs in England offer support to businesses with alternative business models – including Co-operatives and Mutuals, as a condition of funding, and included more information on Co-operatives and Mutuals through the highly successful Help to Grow Management programme.

The Law Commission reviews are considering ways to update and modernise the legislation for co-operatives, community benefit societies, and friendly societies, ensuring that it fits the nature and needs of these societies as well as ensuring that regulation is proportionate and effective. The government will carefully consider the recommendations to understand whether reform is needed to ensure these businesses are supported to grow and succeed into the future.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
23rd Jan 2026
To ask His Majesty's Government what mitigations they have secured under the United States' "Most Favoured Nation" drug pricing initiative as part of the UK–US Economic Prosperity Deal.

The US has committed to ensuring that access to medicines and launches of new innovative medicines in the UK are not inadvertently impacted by the US’s ‘Most Favoured Nation’ policy, thereby reducing the risk to the UK where the NHS has managed to secure lower prices for medicines.

Further work to finalise underpinning details is ongoing.

Lord Stockwood
Minister of State (HM Treasury)
18th Nov 2025
To ask His Majesty's Government what meetings ministers and officials have had with the Competition and Markets Authority (CMA) about (1) the decision to designate Google as having strategic market status in search and search advertising services, and (2) the plan to begin consulting on possible interventions later this year.

Ministers and officials regularly meet with the Competition and Markets Authority to discuss key policy issues, including the CMA’s digital markets work. Close collaboration between Government and the CMA is crucial for delivering the agenda of this Government. As the UK’s independent competition authority, the CMA is responsible for all digital markets decisions, including on designations and interventions.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
18th Nov 2025
To ask His Majesty's Government what meetings ministers and officials have had with representatives of Google about (1) the decision of the Competition and Markets Authority (CMA) to designate Google as having strategic market status in search and search advertising services, and (2) the CMA's plan to begin consulting on possible interventions later this year.

Ministers and officials have met with representatives of Google to discuss a range of topics, including the Competition and Markets Authority’s digital markets work. Such meetings are important for the exchange of views and the development of policy. As the UK’s independent competition authority, the CMA is responsible for all digital markets decisions, including on designations and interventions.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
23rd Oct 2025
To ask His Majesty's Government, further to the answer by Baroness Smith of Malvern on 16 October (HL Deb col 355) that “a statutory probation period will be introduced with light-touch standards for fair dismissal based on performance and stability”, what is the length of that statutory probation period and what are the grounds for dismissal during that period.

Next Steps to Make Work Pay, published in 2024, set out the Government’s preference for the statutory probation period to be nine months long.

Under the Employment Rights Bill, the normal grounds for fair dismissal (under the Employment Rights Act 1996) will apply in this period, and light-touch standards will apply to dismissals for reasons of the employee’s conduct, capability, illegality, or some other substantial reason relating to the employee. The Government believes this will allow businesses to remain confident in hiring.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
2nd Feb 2026
To ask His Majesty's Government what estimate they have made of the investment in vaccines for gingivitis or periodontitis by UK Research and Innovation.

The Medical Research Council (MRC), which is part of UK Research and Innovation (UKRI), is not currently funding any research into vaccines for gingivitis or periodontitis. MRC invests more broadly in dental and oral health research, including some periodontitis research, to aid its detection and treatment.

Lord Vallance of Balham
Minister of State (Department for Energy Security and Net Zero)
10th Nov 2025
To ask His Majesty's Government what assessment they have made of the implications of requiring the use of technology that does not yet exist, or function satisfactorily, in notices under section 121 of the Online Safety Act 2023.

Ofcom will set out what technology is required for a service to comply with a Technology Notice under section 121 of the Online Safety Act. That technology must be accredited as meeting minimum standards of accuracy. Ofcom’s consultation on the minimum standards of accuracy closed in March 2025 and the finalised version will be published in due course.

Where a tech solution does not exist in relation to a particular service design, Ofcom will be able to direct companies to use best endeavours to develop or source technology that deals with child sexual exploitation and abuse content.

Baroness Lloyd of Effra
Baroness in Waiting (HM Household) (Whip)
7th Jan 2025
To ask His Majesty's Government how they are ensuring that digital inclusion is a core consideration, where relevant, when updating existing or delivering new policies across all government departments.

Digital inclusion is a priority for this Government. It means ensuring that everyone has the access, skills, support and confidence to participate in our modern digital society, whatever their circumstances. Work is ongoing to develop our approach to tackling digital exclusion and coordinating across government departments continues to be a core part of this work. We hope to say more on this soon.

26th Nov 2024
To ask His Majesty's Government what assessment they have made of the success of projects arising from the Reducing Drug Deaths Innovation Challenge; and what plans they have to continue or expand upon these projects.

The Reducing Drug Deaths Innovation Challenge funded eleven technologies in its first phase, all of which were completed successfully. Seven projects secured phase 2 funding to advance development of their technologies through testing with relevant populations. The UK Government’s Office for Life Sciences, in collaboration with the Chief Scientist Office in Scotland, is monitoring the progress of these projects and will provide guidance to support commercialisation, spread and UK-wide adoption of the technologies to prevent drug overdose deaths. Future funding and initiatives through the Addiction Healthcare Goals programme are being explored to further encourage innovative research and the development of novel technologies to treat drug and alcohol addictions.

Lord Vallance of Balham
Minister of State (Department for Energy Security and Net Zero)
5th Jan 2026
To ask His Majesty's Government what assessment they have made of concerns within the medical community about potential risks associated with the use of artificial intelligence chatbots by individuals seeking emotional support and companionship when experiencing loneliness.

While no such assessment has been made, this Government recognises the importance of exploring innovative approaches to tackle loneliness, whilst protecting people's safety and wellbeing.

Baroness Twycross
Baroness in Waiting (HM Household) (Whip)
11th Sep 2025
To ask His Majesty's Government what steps they will take to ensure that the local covenant partnerships programme involvements meaningful engagement with civil society bodies such as the National Council for Voluntary Organisations.

Collaboration and partnership are at the heart of the Civil Society Covenant which was launched by the Prime Minister in July at a major civil society summit. To inform the development of the Civil Society Covenant, the Department for Culture, Media and Sport engaged with over 1,200 organisations and worked closely with the Civil Society Advisory Group, including representatives from the National Council for Voluntary Organisations (NCVO) alongside a wide range of other civil society organisations.

At the launch we announced the Joint Civil Society Covenant Council which will be central to the delivery of the Covenant, setting direction and providing strategic oversight for its implementation. It will have cross-sector membership comprising senior leaders from civil society and senior representatives from government departments. We also announced a Local Covenant Partnerships Programme to support collaborative working between civil society organisations, local authorities and public service providers to deliver services that better meet the needs of their communities.

We will continue working in the spirit of partnership as we establish and develop both the Joint Civil Society Covenant Council and the Local Covenant Partnerships Programme.

Baroness Twycross
Baroness in Waiting (HM Household) (Whip)
11th Sep 2025
To ask His Majesty's Government what steps they are taking to engage with civil society bodies such as the National Council for Voluntary Organisations on the Joint Civil Society Covenant Council.

Collaboration and partnership are at the heart of the Civil Society Covenant which was launched by the Prime Minister in July at a major civil society summit. To inform the development of the Civil Society Covenant, the Department for Culture, Media and Sport engaged with over 1,200 organisations and worked closely with the Civil Society Advisory Group, including representatives from the National Council for Voluntary Organisations (NCVO) alongside a wide range of other civil society organisations.

At the launch we announced the Joint Civil Society Covenant Council which will be central to the delivery of the Covenant, setting direction and providing strategic oversight for its implementation. It will have cross-sector membership comprising senior leaders from civil society and senior representatives from government departments. We also announced a Local Covenant Partnerships Programme to support collaborative working between civil society organisations, local authorities and public service providers to deliver services that better meet the needs of their communities.

We will continue working in the spirit of partnership as we establish and develop both the Joint Civil Society Covenant Council and the Local Covenant Partnerships Programme.

Baroness Twycross
Baroness in Waiting (HM Household) (Whip)
17th Sep 2025
To ask His Majesty's Government what steps they are taking to ensure that all primary school pupils leave school with the ability to swim competently and an understanding of water safety.

Swimming and water safety are vital life skills that are compulsory elements of the PE National Curriculum at key stages 1 and 2. In addition, the changes made to the department’s statutory relationships, sex and health education guidance will ensure all pupils are taught about the water safety code, supporting them to be safe in different types of water. To support schools, Oak National Academy offers swimming and water safety units as part of its PE curriculum, developed in partnership with Swim England.

In June, my right hon. Friend, the Prime Minister announced a new national approach to PE and school sport as part of which we will establish a PE and School Sport Partnership Network, designed to build stronger links between schools, local clubs, and National Governing Bodies. It will identify and remove barriers to participation in PE and school sport, including swimming.

The department is also providing a grant of up to £300,000 to deliver Inclusion 2028, a programme which upskills teachers to deliver high quality, inclusive PE, including swimming and water safety, to pupils with special educational needs and disabilities.

Baroness Smith of Malvern
Minister of State (Department for Work and Pensions)
24th Jun 2025
To ask His Majesty's Government, following the announcement of the end of international recruitment of social care workers, what plans they have to train British residents, in particular those who are unemployed, to become part of the social care workforce through (1) Skills England, and (2) other ring-fenced funding programmes.

Skills England, and its predecessor the Institute for Apprenticeships and Technical Education (IfATE), has worked with employers to develop apprenticeships covering a range of occupations in the care services sector. These are designed to enable an individual to acquire full competence in an occupation whilst undertaking paid work and provide a progression route in the sector. These products are available for both public and private sector employers to use, with funding to support the training from the Growth and Skills Levy.

In addition, a Health and Social Care foundation apprenticeship has been developed and will be available for delivery from autumn this year. This is specifically aimed at young people who are not yet ready for work, and will provide the individual with a mix of employability and sectoral skills designed to provide a good grounding for a career in the health or adult social care sector.

To support the awareness of careers in adult social care, the National Careers Service, a free, government funded careers information, advice and guidance service, uses a range of labour market information to support and guide individuals. The Service website gives customers access to a range of digital tools and resources, including ‘Explore Careers’ which includes more than 130 industry areas and more than 800 job profiles including a range of construction and health and social care roles, describing what the roles entail, qualifications needed and entry routes.

Baroness Smith of Malvern
Minister of State (Department for Work and Pensions)
12th Jan 2026
To ask His Majesty's Government what assessment they have made of the introduction of a transition period for products with a shelf life of three to five years that will be affected by the sanitary and phytosanitary agreement with the EU to prevent waste.

The Government is currently negotiating a Sanitary and Phytosanitary Agreement to make agrifood trade with our biggest market cheaper and easier, cutting costs and red tape for British producers and retailers, and helping to reduce the pressure on prices and increase choice in the shops.

We are working closely with businesses to assess the implementation impacts of the Agreement.

Baroness Hayman of Ullock
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
12th Jan 2026
To ask His Majesty's Government whether they have considered the impact of the sanitary and phytosanitary agreement with the EU on additives in vitamins, including the Healthy Start Vitamins.

We have begun negotiations with the EU on an SPS agreement to make agrifood trade with our biggest market cheaper and easier, cutting costs and removing barriers to trade for British producers and retailers. While negotiations with the EU on the SPS agreement are underway, we will not be providing a running commentary of discussions.

Baroness Hayman of Ullock
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
12th Jan 2026
To ask His Majesty's Government what assessment they have made of (1) the size of the probiotics market in the UK, and (2) its potential for growth.

The size of the probiotics market in the United Kingdom was £1.07 billion in 2024 (table 1, Euromonitor International*). The UK market value for probiotic products grew by 19% between 2019 and 2024 (in 2024 prices) and 41% by sales volumes. Recent growth in the probiotic market has been attributed to the increasing popularity of probiotic dairy products like Kefir.

Table 1 – UK probiotic product retail sales (GBP million, Euromonitor)

Category

2019

2020

2021

2022

2023

2024

Probiotic Dairy

690.8

780.0

867.5

949.6

999.5

1,051.8

Probiotic Butter and Spreads

7.3

7.3

8.0

9.8

11.1

10.6

Probiotic Other Dairy

4.9

5.8

5.5

7.5

7.5

10.1

Probiotic Snacks

0.5

0.7

3.4

1.5

1.1

1.8

Probiotic Carbonates

0.2

0.3

0.3

0.3

0.3

0.6

Probiotic Cheese

1.6

1.4

0.0

0.0

-

0.0

Total UK Market

705.3

795.5

884.7

968.7

1,019.5

1,074.9

Euromonitor have considered growth in the wider UK diary and dairy alternatives market and forecast that the value of probiotic dairy market will grow by 14% up to 2029, to £1.2 billn. There is no forecast for the overall probiotics market, but as probiotic dairy products make up 99% of the market by volume, this forecast is sufficient for the market overall.

*Although Euromonitor aims to correct inaccuracies of which it is aware, it does not warrant that the Intelligence will be accurate, up-to-date or complete as the accuracy and completeness of the data and other content available in respect of different parts of the Content will vary depending on the availability and quality of sources on which each part is based. Euromonitor accepts no liability in regard to the derived data which has been presented here and furthermore, Euromonitor does not warrant that the Intelligence will be/is fit for any particular purpose(s) for which they are used as Euromonitor does not have any knowledge of, nor control over, those purposes.

Baroness Hayman of Ullock
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
18th Sep 2025
To ask His Majesty's Government whether they plan to develop a cross-departmental drowning prevention strategy for unguarded waters.

Responsibilities for water safety sit with various Government departments, agencies, local authorities, and other public bodies. These include regular safety messaging and guidance to ensure people have the knowledge they need to keep themselves safe, as well as provision of safety/lifesaving equipment at water bodies. Water sports national governing bodies are responsible for providing advice and guidance for how to participate in their sports safely. Inland waterway navigation authorities conduct risk assessments to inform the provision of appropriate lifesaving equipment on their networks. In conjunction with other services, HM Coastguard provides safety advice and guidance about the coastal environment.

The National Water Safety Forum brings together a wide range of national groups, including some 80 local authorities, to create a ‘one-stop shop’ for the prevention of drowning and water safety harm in the UK. The Forum launched the UK Drowning Prevention Strategy 2016-2026 (copy attached), which aims to reduce the number of accidental drownings in the UK by 50% by 2026. The Local Government Association has developed a water safety toolkit (copy attached) for local authorities for use inland and on the coast.

Baroness Hayman of Ullock
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
17th Sep 2025
To ask His Majesty's Government what plans they have to review water safety provision at public beaches, rivers and lakes without lifeguard supervision, and whether they will issue additional guidance to local authorities.

Responsibilities for water safety sit with various Government departments, agencies, local authorities, and other public bodies. These include regular safety messaging and guidance to ensure people have the knowledge they need to keep themselves safe, as well as provision of safety/lifesaving equipment at water bodies. Water sports national governing bodies are responsible for providing advice and guidance for how to participate in their sports safely. Inland waterway navigation authorities conduct risk assessments to inform the provision of appropriate lifesaving equipment on their networks. In conjunction with other services, HM Coastguard provides safety advice and guidance about the coastal environment.

The National Water Safety Forum brings together a wide range of national groups, including some 80 local authorities, to create a ‘one-stop shop’ for the prevention of drowning and water safety harm in the UK. The Local Government Association has developed a water safety toolkit (copy attached) for local authorities for use inland and on the coast.

Baroness Hayman of Ullock
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
10th Feb 2025
To ask His Majesty's Government, further to the Written Answer by Baroness Hayman of Ullock on 20 January (HL3929), what discussions they have had with Ofwat and water companies about encouraging domestic household customers to install rainwater harvesting systems.

I refer the hon. Member to the reply previously given on 20 January 2025, PQ HL3929, as no further discussions with Ofwat or water companies have taken place since.

Baroness Hayman of Ullock
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
9th Jan 2025
To ask His Majesty's Government what discussions they have had with Ofwat and water companies about encouraging or incentivising domestic and business customers to install rainwater harvesting systems.

The Government recognises that rainwater harvesting and other forms of water reuse can play a key role in helping non-households and businesses meet the statutory water demand reduction target of 9% by March 2038. We are therefore supporting water companies and developers to deliver water efficiency through both rainwater harvesting and other forms of water reuse.

We supported Ofwat on their consultation to provide environmental incentives to developers which included considering where new technologies and water efficient practices could be integrated into buildings and developments. Ofwat reported that water reuse solutions are likely to be an important tool for improving water efficiency in the medium term.

We are also looking into allowing water companies to supply treated, non-potable water, including rainwater, for certain water demands such as toilet flushing.

Baroness Hayman of Ullock
Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
9th Mar 2026
To ask His Majesty's Government how the Keep Britain Working Review will help to incentivise businesses of all sizes to support the health and wellbeing of their employees.

Through the next phase of Keep Britain Working we will work with businesses of all sizes to design solutions which support the health and wellbeing of employees across the UK. Through employer-led sprints, we are developing a Healthy Working Lifecycle Standard, tailored workplace health support, and stronger evidence on the business benefits of investing in employee wellbeing.

Our Vanguard group includes over 120 employers of varying sizes to ensure the approaches developed reflect the needs and realities of both large employers and SMEs. We are also working closely with regional authorities and leadership to connect the programme to smaller employers across the country.

During the Keep Britain Working review, we heard that employers are already bearing the cost of sickness absence and employees leaving the workforce and are therefore highly incentivised to support the health and wellbeing of their employees. Through the next phase of Keep Britain Working we will grow the evidence for what works and where additional incentives could have the greatest impact, ensuring that support is targeted in ways that encourage employers to take-up effective workplace health measures.

Baroness Sherlock
Minister of State (Department for Work and Pensions)
18th Mar 2026
To ask His Majesty's Government, further to the remarks by Baroness Merron on 9 March (HL Deb col 9), what steps they plan to take to ensure the integration of care between the proposed National Care Service and the National Health Service.

The Government is committed to ensuring joined up health and care services. While the Independent Commission will inform the long-term direction of a national care service, the Government is already progressing reforms to strengthen the join up between services, so people experience more integrated and person-centred care.

We are developing Neighbourhood Health Services, which will allow more integrated working within the National Health Service, as well as between the NHS, local government, and a wide range of public services, including the voluntary, community, and social enterprise sector. The National Care Service and the Neighbourhood Health Service will play a critical role in helping people stay independent for longer, minimising the time that they need to spend in hospital or in long-term residential care.

Alongside this, we are improving national data and digital infrastructure, including driving the adoption of digital and social care records so people get the right care quicker, without needing to repeat their care needs or medical history.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
18th Mar 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 23 February (HL14441), what assessment they have made of the impact of the National Institute for Health and Care Excellence guidelines on generalised anxiety and panic disorder on access to treatment for marginalised groups.

The Department has made no assessment of the impact of the National Institute for Health and Care Excellence (NICE) guidelines on generalised anxiety and panic disorder or on access to treatment for marginalised groups.

NICE keeps its published guidelines under active surveillance and decisions on whether they should be updated in light of new evidence are taken by the NICE prioritisation board in line with its published prioritisation framework. NICE’s prioritisation board will be considering whether the guideline on generalised anxiety and panic disorder should be updated following a letter from the UK Council for Psychotherapy.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
11th Mar 2026
To ask His Majesty's Government what steps they will take to prioritise rare cancers research in the next round of National Institute for Health and Care Research funding allocations; and what proportion of the overall cancer research budget will be allocated to (1) brain, (2) liver, (3) stomach, (4) pancreatic, and (5) oesophageal, cancers.

Government responsibility for delivering cancer research is shared between the Department of Health and Social Care, with research delivered by the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.

The Government will implement the Rare Cancers Act to make it easier for clinical trials on rare cancers to take place in England.

The NIHR welcomes funding applications for research into any aspect of human health and care, including rare cancers. Our approach to funding research is through open and fair competition and peer review to ensure that the highest-quality proposals, most likely to deliver real impact for patients, are funded without imposing financial targets or limits.

Welcoming applications on rare cancers to all NIHR programmes enables maximum flexibility both in terms of amount of research funding a particular area can be awarded, and the type of research which can be funded.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
11th Mar 2026
To ask His Majesty's Government what steps they are taking to implement the automatic patient contact system for clinical trial participation introduced as part of the Rare Cancers Act 2026 to enable the timely identification and contact of patients diagnosed with less survivable cancers; and what safeguards they will put in place to prevent delays in that contact system that could exclude eligible patients from participation in clinical trials.

The Department is committed to ensuring that all patients, including those with a rare cancer, have access to cutting-edge clinical trials and innovative, lifesaving treatments.

As set out in our National Cancer Plan, the Government will implement the Rare Cancers Act, including Section 3 of the Act which will involve developing a service to ensure rare cancer patients can be automatically contacted about clinical trials.

The Government is currently scoping the technical requirements for this service and identifying a suitable route for delivery, before a development project is commenced. This will allow data sharing from the National Disease Registration Service to the National Institute for Health and Care Research’s Be Part of Research registry tool. A detailed workplan and continued engagement with the Hon. Member Dr Scott Arthur, the bill sponsor in the House of Commons, will safeguard against delays which could impact the project.

Implementing the provisions of the Rare Cancers Act will make it easier for clinical trials on rare cancers to take place in England.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
11th Mar 2026
To ask His Majesty's Government whether they will publish separate, individual-level performance data for (1) brain, (2) liver, (3) lung, (4) stomach, (5) pancreatic, and (6) oesophageal, cancers under the Get Data Out programme.

Improving outcomes for rare cancer patients is a priority for the National Cancer Plan. The National Disease Registration Service (NDRS) in NHS England, as the national cancer registry, collects diagnosis, treatment, and outcome data on cancer patients in England. All these cancer sites, such as brain, liver, lung, stomach, pancreatic, and oesophageal, are already included in NDRS’ Get Data Out (GDO) programme. Performance data is not included in GDO but incidence, treatment, survival, and routes to diagnosis statistics are available for the clinically meaningful groups of cancers included.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
10th Mar 2026
To ask His Majesty's Government what steps they are taking to address regional disparities in thyroid treatment, particularly variations in prescribing liothyronine between different integrated care boards.

Integrated care boards (ICBs) are responsible for supporting appropriate prescribing in their areas, taking account of this guidance and individual clinical circumstances.

National Health Service regions cascaded the Items which should not be routinely prescribed in primary care policy guidance, which includes a reference to liothyronine, to ICBs.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
9th Mar 2026
To ask His Majesty's Government what assessment they have made of the role the independent sector can play in supporting the development of NHS Online.

NHS Online, launching in 2027, will be a publicly owned National Health Service organisation, giving patients on certain pathways the choice of getting the specialist care they need from their home. It will offer the latest innovations in digital healthcare, nationally scaled for the benefit of patients in every part of the country, helping to reduce patient waiting times through delivering the equivalent of up to 8.5 million appointments and assessments in its first three years.

The Government recognises the role independent sector providers have in supporting the NHS as trusted partners to recover elective services by using additional capacity to tackle the backlog whilst delivering value for money.

The NHS Online programme is actively engaging with both NHS organisations and the independent sector, including through representative bodies such as the Independent Healthcare Providers Network, to support the development of NHS Online.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
9th Mar 2026
To ask His Majesty's Government how many notifications NHS England has received under section 4.1.8 of the Data Sharing Framework version 2.03, or equivalent textual clauses in earlier versions, in (1) 2023, (2) 2024, (3) 2025, and (4) 2026.

Since 2023, NHS England has received the following number of data breach notifications from data recipients under section 4.1.8 of the Data Sharing Framework:

- from March 2023, when NHS Digital and NHS England merged, to December 2023 there were zero;

- in 2024 there were three;

- in 2025 there were five; and

- in 2026 there were two.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
9th Mar 2026
To ask His Majesty's Government what progress they are making to facilitate data sharing between the NHS and the independent sector.

Information standards relating to information technology will enable the interoperability needed for information to be shared easily between the National Health Service and the independent sector.

The Health and Care Act 2022 made several changes to the information standard provisions of the 2012 act which will strengthen information standards for the health and adult social care system, including extending their scope to include private health and care providers and making compliance with standards mandatory. These provisions have now commenced.

The Single Patient Record will, in the future, be central to our vision for data within the NHS and social care. A seamlessly connected NHS where trusted data flows securely across all care settings, empowering patients, enabling clinicians with real-time insights, and unlocking breakthroughs in genomics, improve outcomes, and reduce inequalities. We will require public and private health and social care providers and their IT suppliers to share health and adult social care information with the Single Patient Record.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
9th Mar 2026
To ask His Majesty's Government what steps they are taking to build trust in digital healthcare.

The Government recognises the importance of building trust in digital health systems and how critical this is to retaining public confidence. As part of its 10-Year Health Plan, the Government is providing a digitisation programme that supports National Health Service frontline clinicians and patients in improving outcomes and delivering care efficiently, effectively, and safely across the system.

The Government has also worked with NHS stakeholders and the public to ensure that the changes made respect privacy and confidentiality and maintain trust in the system. To help better understand the public's views, we carried out a series of engagement events, the reports for which were published online.

Our other initiatives include a revised NHS Data Security and Protection Toolkit which allows the NHS to assess their performance against national security standards and the development of secure data environments to help ensure that research and analysis requiring NHS data is done in a way that is protected, auditable, and which maintains privacy.

The training of NHS staff so that they are digitally confident and have skills in modern leadership and innovation, is another priority.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
9th Mar 2026
To ask His Majesty's Government what consideration they have given to allowing children and young people with non-malignant conditions who travel long distances to receive stem cell transplants and chimeric antigen receptor T-cell therapy access to the young cancer patient travel fund announced as part of the National Cancer Plan for England, published on 4 February.

The commitment to fund travel costs of up to £10 million per year to support children and young people with cancer is a key priority for the National Cancer Plan.

The Department is currently working with its partners to define the scope and parameters of the scheme and further detail will be announced in due course.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
4th Mar 2026
To ask His Majesty's Government what assessment they have made of the recommendation in the report by the UK BioIndustry Association From innovation to impact: unlocking patient access to innovative rare disease medicines, published on 4 December 2025, to develop a separate evaluation pathway for innovative orphan medicines where a cost-effectiveness based evaluation is not appropriate, and of its implementation.

There are no plans to introduce a separate evaluation process for orphan medicines. Most medicines, including orphan medicines, are assessed through the National Institute for Health and Care Excellence’s (NICE) standard technology appraisal programme, with a small number of treatments for very rare and severe conditions considered through the highly specialised technologies programme, which applies a higher cost-effectiveness threshold.

NICE’s methods are suitable for evaluating rare disease medicines where prices are set fairly. Approval rates for rare disease medicines are in line with overall NICE recommendations, and between April 2024 and April 2025 NICE recommended all 15 rare disease medicines assessed through the standard programme.

We are also investing approximately 25% more in innovative treatments through an increase to NICE’s cost-effectiveness threshold and changes to how health benefits are valued. This will support access to medicines delivering significant health benefits, including for rare diseases, that may previously have been declined on cost-effectiveness grounds.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
4th Mar 2026
To ask His Majesty's Government what steps they are taking to expand new-born screening in line with its ambition in the 10 Year Health Plan to roll out whole genome sequencing by 2030; and what interim targets they have established to measure progress towards this ambition.

The 10-Year Health Plan set out an ambition to “implement universal genomic testing” within the next decade. Delivering against this ambition will be subject to evidence gathered through the Generation Study. This research programme is evaluating the effectiveness of using whole genome sequencing to test 100,000 newborns for genetic mutations associated with more than 200 rare genetic conditions. The sequencing of 100,000 newborns through the Generation Study will be completed by summer 2027. The evaluation part of the study will then be completed and presented to the UK National Screening Committee who will make a recommendation to Government ministers on whether newborn genomic screening should be offered in the National Health Service or whether more research is required. Subject to this, and appropriate funding being available, genomic testing could be available for all newborns by 2035.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
4th Mar 2026
To ask His Majesty's Government what interim targets they have set to meet the commitment in the Life Sciences Sector Plan for the UK to become one of the three fastest countries in Europe for patient access to medicines by 2030.

The Life Sciences Sector Plan includes a broad range of commitments to support our ambitions to be one of the top three fastest places in Europe for patient access to medicines by 2030. This includes improving capacity and efficiency in delivering commercial clinical trials, investing in innovation, and supporting access and uptake across the system.

The target itself will be measured by the European Federation of Pharmaceutical Industries and Associations Waiting to Access Innovative Therapies indicator. The latest data shows that the median time between regulatory approval and patient availability for medicines launched between 2020 and 2023 was 310 days for England and 303 days for Scotland, compared to a European Union median of 518 days.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
4th Mar 2026
To ask His Majesty's Government what assessment they have made of the effectiveness of the NHS new-born blood spot programme; and what steps they have taken to bring the UK in line with other European countries on the number of conditions screened for.

The NHS Newborn Blood Spot Programme consistently achieves very high coverage with the most recent figure at 98% in Quarter 2 of 2025/26. This not only indicates that eligible babies are being screened, but also that conclusive results are recorded on the Child Health Information Service system before or at 17 days of age, indicating that the programme is effective at reaching almost the entire eligible population and delivering results early enough to influence outcomes.

Coverage of babies who move into the area after birth is lower at 83%, so the programme is less effective for this subgroup, but numbers are much smaller.

A total of 570,865 babies were screened in 2024/25, demonstrating the programme is operating effectively at scale, and the system is robust enough to deliver screening across a large cohort.

Over one million babies have been screened for severe combined immunodeficiency since the launch of the in-service evaluation (ISE) in 2017. NHS England’s report on the 30-month ISE evaluation period found that screening detected 10 babies with the condition who would otherwise have gone undetected until infections developed, thus preventing serious illness.

It is important to note that comparisons of screening programmes with other health systems can be misleading. Some countries or regions reportedly screen for a condition when it is only at the pilot or research stage. Some ‘screening programmes’ just test for a condition rather than being end-to-end quality-assured programmes that include diagnosis, treatment, and care. And screening in some countries is delivered regionally, or even just by individual hospitals, rather than nationally. They are therefore not directly comparable to the national screening programmes offered in the United Kingdom.

For very rare conditions it is difficult to generate robust evidence to demonstrate the value of screening, because so few babies are affected. The UK National Screening Committee, which advises the Government on all screening matters, is working with experts and partner organisations to look at how to make it easier to develop the evidence needed to make robust recommendations on the addition of more rare diseases to the NHS Newborn Blood Spot Programme.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
3rd Mar 2026
To ask His Majesty's Government what steps they are taking to reduce the daily average of 13,823 medically fit patients who remained in hospital in January, in particular in regard to social care capacity.

The Government is taking a range of steps to reduce the number of medically fit patients who remain in hospital and recognises that timely discharge is essential for improving patient outcomes and freeing up capacity. Through the Better Care Fund (BCF), £9 billion is available in 2025/26 and a further £9 billion has been committed in 2026/27, which is being pooled to strengthen social care capacity, deliver more joined‑up support, and reduce delays to discharge.

A central aim of the BCF is to support services that help people regain independence, prevent avoidable admissions, and enable timely discharge, with greater emphasis on intermediate care services that can meet both step‑up and step‑down needs.

The BCF also requires systems to set goals to reduce non‑elective admissions for people aged 65 years old and over and discharge delays, ensuring BCF‑funded activity directly supports improved hospital flow.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
3rd Mar 2026
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 16 February (HL14437), what evidence they have reviewed on the economic value and cost-effectiveness of point-of-care diagnostic testing technologies for cardiovascular disease prevention.

We recognise the value of point-of-care diagnostics in enabling earlier detection, reducing avoidable hospital admissions, and supporting more personalised care.

The National Institute for Health and Care Excellence (NICE) has produced clinical guidelines and heath technology guidance which make recommendations on the use of point-of-care testing (POCT) for a range of conditions and diseases. Decisions as to whether NICE will create new, or update existing, guidance are overseen by a prioritisation board, chaired by NICE’s Chief Medical Officer.

Decisions on the use and implementation of POCT are made locally by integrated care boards and providers, who design services in line with local population health needs and priorities.

The Cardiovascular Disease (CVD) Modern Service Framework will be published later this year and will prioritise ambitious, evidence-led, and clinically informed approaches to prevention, treatment, and care. As part of its development, we are engaging widely to identify and consider the role of emerging innovations across the CVD pathway.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
2nd Mar 2026
To ask His Majesty's Government what plans they have to implement a community pharmacist prescribing service.

The Government is committed to expanding the role of pharmacies and better utilising the skills of pharmacists and pharmacy technicians. This includes our commitment to make prescribing part of the services delivered by community pharmacists. The NHS Medium Term Planning Framework supports this ambition by instructing integrated care boards that they must introduce prescribing based services into community pharmacies during 2026/27 to support primary care access. From September 2026, all newly qualified pharmacists will be independent prescribers upon registration.

The Department is currently in consultation with Community Pharmacy England on the 2026/27 Community Pharmacy Contractual Framework. This consultation will consider any proposed changes to the reimbursement and remuneration of pharmacy contractors in 2026/27, including considering the introduction of prescribing into community pharmacy services. Once this consultation has concluded, the results will be formally announced.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
2nd Mar 2026
To ask His Majesty's Government what is the total number of medical specialty training posts available for doctors to apply for (1) this year, and (2) in the next two years.

There are currently approximately 9,500 specialty training places. We set out in the 10-Year Health Plan for England that over the next three years we will create 1,000 new specialty training posts, with a focus on specialties where there is greatest need. We will set out next steps in due course.

The Government is committed to training the staff we need, including doctors, to ensure patients are cared for by the right professional, when and where they need it. We will publish a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed services set out in the 10-Year Health Plan.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
2nd Mar 2026
To ask His Majesty's Government whether they have made an assessment of the potential benefits of offering prehabilitation to all patients on surgical waiting lists.

The Elective Reform Plan set out the reform and productivity efforts needed to reach the 92% referral to treatment standard by March 2029. As part of that, we will ensure that patients are seen on time and have the best possible experience during their care. Improving perioperative care can increase productivity by reducing cancellations, reducing length of stay, and minimising postoperative complications.

Prehabilitation services will be offered to patients on admitted pathways who have been screened for modifiable risk factors which could be improved by prehabilitation services. In particular, NHS England will work through Cancer Alliances to support improvements in prehabilitation for people about to undergo cancer treatment. The level of prehabilitation offered will be dependent on both patient risk factors and surgical complexity, and is guided by the clinical evidence base on these factors on the application of appropriate universal or targeted interventions

There are no current plans to assess the potential merits of extending these services to all patients referred for surgery.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
2nd Mar 2026
To ask His Majesty's Government what assessment they have made of the adequacy of the support provided to clinicians for post-deployment monitoring of new artificial intelligence tools introduced to local services.

The Government recognises that effective post‑deployment monitoring of artificial intelligence (AI) tools is essential to maintaining patient safety and supporting clinicians in their day‑to‑day practice.

The Government has not conducted a single, centralised assessment of post‑deployment support for all AI tools used in local services. Instead, responsibility for ensuring appropriate monitoring and clinical support sits with local National Health Service organisations, working within national regulatory and governance frameworks.

Nationally, NHS England and the Department have published guidance and regulatory support to help organisations safely deploy and oversee AI technologies. This guidance is currently provided through a combination of regulatory frameworks, clinical safety standards, and product specific national guidance, rather than a single consolidated framework. As set out in the 10-Year Health Plan and the developing AI Strategic Roadmap, the Government is working towards a more coherent, end to end approach to supporting the safe adoption, monitoring, and governance of AI across health and care. This is being done in conjunction with regulators such as the Medicines and Healthcare products Regulation Agency, the National Institute for Health and Care Excellence, the Health Research Authority, and the Care Quality Commission.

Local adopters are expected to ensure that clinicians are supported through appropriate training, access to clinical safety expertise, and clearly defined monitoring arrangements proportionate to the risk and intended use of the AI tool. This includes maintaining oversight of real‑world performance and taking action where tools do not perform as intended.

The Government continues to work closely with NHS England, clinicians, and regulators to keep guidance under review and to identify where further support may be required, as the use of AI in health and care continues to evolve.

Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)